See how physicians sequence therapy across every Medicare FFS patient.

Treatment sequences, switches, and time on therapy, traced at the NPI level through 25 years of Medicare Fee-for-Service claims. A census of the patients your sequencing model is meant to describe, observed rather than projected.

Longitudinal treatment viewIllustrative
JANFEBMARAPRMAYPatient A 1L 2L comboPatient B 1L 2L 3LPatient C 1L 2L
Line transition

Patient Journey and Line of Therapy (LoT)​

What it is

Longitudinal mapping of treatment sequences, therapy switches, and persistence across 100% of Medicare FFS claims with 25 years of historical depth.

Who needs it

Brand, HEOR, medical affairs, and market access teams in competitive therapeutic areas where sequencing strategy drives revenue.

The pain

Sequencing decisions are being made on clinical trial assumptions or projected commercial data. You can't see how physicians actually use therapies across lines, or what happens after patients leave your brand.

Therapeutic areas
Oncology Rare Disease Neurology Immunology Cardiology Ophthalmology Adult Vaccines Pulmonology
So what?

Every line of therapy decision is a revenue decision. If your sequencing model is wrong, your call plan, your launch forecast, and your positioning are wrong. CareSet's LoT work is how clients find out where their model diverges from observed physician behavior in Medicare, before that gap shows up in sales results.

What CareSet Delivers

CareSet — Get Started

Treatment Sequences

First-line through subsequent lines at the NPI level: what physicians prescribe, in what order, and how long patients stay on therapy before switching.

Switch Analysis

When and why patients move between therapies. Tracked by physician, geography, and time period.

Time-on-Therapy

Persistence measured across products and physician segments. Identifies where early discontinuation concentrates.

Diagnostic Pathway

Upstream trace from initial presentation through testing, referral, and treatment initiation.

25-Year Lookback

The deepest longitudinal depth available for tracking treatment evolution over time.

Monthly Census Refresh

~2-week lag from CMS. Every update reflects 100% of Medicare FFS, not a refreshed sample.

Competitive positioning

VS.Their LimitationCareSet's Position
PLD Vendor
Medicare data derived from commercial claims partnerships, not a direct CMS relationship. Projected, not census. They get their Medicare data from us.
100% FFS coverage. Every Medicare claim, observed. No extrapolation.
Commercial Claims
Sample-based and structurally incomplete in Medicare-heavy populations (65+). More frequent updates don't fix incomplete denominators.
The completeness problem is structural. Monthly refreshes on partial data are still partial data.
VRDC Self-Service
Same raw data access, but clients consistently find they cannot replicate CareSet's LoT algorithm depth.
VRDC access gives you data. CareSet brings 10+ years of working with Medicare claims data, answering complex questions to help launch 200+ brands.
25-year lookback, deepest in Medicare
6+ week delivery, collaborative scoping
Every deliverable passes CMS privacy audit
DUA with CMS since 2012, 12+ years